Literature DB >> 6329006

Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung.

E H Lipford, J C Eggleston, K D Lillemoe, D L Sears, G W Moore, R R Baker.   

Abstract

The gross pathological, microscopic, and clinical features of 173 Stage I and Stage II primary nonsmall cell carcinomas resected for cure by segmental resection, lobectomy, or pneumonectomy at the Johns Hopkins Hospital were analyzed to determine which provided useful independent prognostic information. The tumors studied included 79 squamous carcinomas (56%); 74 adenocarcinomas (44%), including 15 undifferentiated tumors which contained intracellular mucin; 18 large-cell undifferentiated carcinomas (10%); one giant cell carcinoma (less than 1%); and one adenosquamous carcinoma (less than 1%). Clinical features evaluated for each case included age, sex, race, and history of previous or subsequent malignancy; and pathologic features evaluated included tumor size, lymph node metastases, tumor location, cellular anaplasia, desmoplastic response, inflammatory response, preexisting scar, tumor necrosis, and degree of tumor differentiation. Multivariate analysis using the Cox life table regression model indicated that five features had a significant (p less than 0.05) independent association with subsequent death due to the tumor, and that the final set was highly significant (p = 0.001). These features were the following: large-cell undifferentiated histology, lymph node metastases expressed as N classification, tumor size expressed as T classification, tumor giant cells in any histologic type, and absent or minimal plasma cell infiltration. No additional prognostic information was obtained from any of the other features analyzed.

Entities:  

Mesh:

Year:  1984        PMID: 6329006     DOI: 10.1097/00000478-198405000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  11 in total

1.  Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633.

Authors:  Stephen L Graziano; Lin Gu; Xiaofei Wang; Arthur H Tatum; Robin T Vollmer; Gary M Strauss; Robert Kratzke; Arkadiusz Z Dudek; Everett E Vokes; Mark R Green
Journal:  J Thorac Oncol       Date:  2010-06       Impact factor: 15.609

2.  Computed tomography (CT) predicts accurately the pathologic tumour size in stage I non-small-cell lung cancer (NSCLC).

Authors:  Susana Cedrés; Isela Quispe; Pablo Martínez; Marina Longo; Eva Rodríguez; César Serrano; Eva Muñoz; Esther Pallisa; Enriqueta Felip
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

3.  Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinoma.

Authors:  José Manuel Ruiz-Morales; Rita Dorantes-Heredia; Oscar Arrieta; Norberto C Chávez-Tapia; Daniel Motola-Kuba
Journal:  Tumour Biol       Date:  2014-12-27

4.  Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITA.

Authors:  Stephen L Graziano; Benjamin Lacas; Robin Vollmer; Robert Kratzke; Helmut Popper; Martin Filipits; Lesley Seymour; Frances A Shepherd; Rafael Rosell; Anne Sophie Veillard; Miquel Taron; Jean-Pierre Pignon
Journal:  Lung Cancer       Date:  2013-08-04       Impact factor: 5.705

5.  Staining pattern of type IV collagen and prognosis in early stage adenocarcinoma of the lung.

Authors:  N Watanabe; I Nakajima; S Abe; S Ogura; H Isobe; Y Kawakami
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

6.  Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer.

Authors:  L L Cunha; R C Ferreira; M A Marcello; J Vassallo; L S Ward
Journal:  J Thyroid Res       Date:  2011-02-17

7.  A comparison of patient survival and tumour growth kinetics in human bronchogenic carcinoma.

Authors:  K M Kerr; D Lamb
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

Review 8.  Necrosis and apoptotic index as prognostic factors in non-small cell lung carcinoma: a review.

Authors:  Charalampos Gkogkou; Konstantina Frangia; Muhammad W Saif; Rodoula Trigidou; Konstantinos Syrigos
Journal:  Springerplus       Date:  2014-03-01

9.  Retention index of thallium-201 single photon emission computerised tomography (SPECT) as an indicator of metastasis in adenocarcinoma of the lung.

Authors:  H Takekawa; K Itoh; S Abe; S Ogura; H Isobe; N Sukou; M Furudate; Y Kawakami
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

10.  Location of stage I-III non-small cell lung cancer and survival rate: Systematic review and meta-analysis.

Authors:  Hyun Woo Lee; Chang-Hoon Lee; Young Sik Park
Journal:  Thorac Cancer       Date:  2018-09-27       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.